Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in
the Anaesthetic Management of a Parturient with Becker's
Myotonia Congenita

J 2016

Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita

KOSINOVÁ, Martina; Petr ŠTOURAČ; Hana HARAZIM; Petr JANKŮ; Martin HUSER et al.

Základní údaje

Originální název

Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita

Název česky

Anestezie a vzácné choroby: Rokuronium a sugammadex v anesteziologickém postupu u rodičky s Beckerovou myotonií

Autoři

KOSINOVÁ, Martina; Petr ŠTOURAČ; Hana HARAZIM; Petr JANKŮ ; Martin HUSER a Stanislav VOHÁŇKA

Vydání

European Journal of Anaesthesiology, Philadelphia, Lippincott Williams & Wilkins, 2016, 0265-0215

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30214 Obstetrics and gynaecology

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 3.570

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00090116

Organizační jednotka

Lékařská fakulta

Klíčová slova česky

císařský řez; Beckerova myotonie; celková anestezie; sugammadex; rokuronium

Klíčová slova anglicky

cesarean delivery; Becker's myotonia congenita; general anaesthesia; sugammadex; rocuronium

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 9. 2016 18:42, Soňa Böhmová

Anotace

ORIG CZ

V originále

Becker's Disease is an autosomal recessive type of myotonia congenita. Worldwide prevalence is about 1/100000. It is linked to mutations in CLCN1, the gene encoding skeletal muscle chloride channel. It reduces flow of chloride ions during repolarization and leads to sustained muscle contractions. Typical clinical symptoms are myotonic stiffness and “warm-up” phenomenon. 27 year old primipara with homozygote recessive mutation in CLCN1 (c.1437_1450del,p.480HfsX24) was indicated to elective caesarean section in 40 gestational week. In personal history she had thoracic stabilisation for scoliosis and hypothyreosis. We decided to provide the general anaesthesia with propofol in TCI mode (Schnider mode, C e =effective concentration 5 mcg/ml) and rocuronium 1 mg/kg IV for rapid sequence induction, monitoring the depth of neuromuscular blockade (NMB) on TOF WATCH SX device. The male newborn (APGAR score 9-10- 10) with no signs of pathology in acid-base balance in arterial umbilical blood was delivered. At the end of surgery (C e =1 mcg/ml, TOF=0, PTC=0) we administered sugammadex 4 mg/kg IV. It takes 2 min and 15 sec to reach TOF ratio 90% and subsequent extubation. After extubation she was breathing adequately, communicative, transferred to the recovery room and after two hours with no signs of residual NMB or respiratory problems back to the gynaecological ward to the monitored postoperative room. She was discharged home on 4 th day. This is the first report of anaesthetic management of a parturient with Becker's myotonia congenita who underwent CS under general anaesthesia. In this case we wanted to aware of using malignant hyperthermia (MH) triggering drugs, though the association with MH has been regarded as highly unlikely, suxamethonium which can cause total body rigidity and subsequent difficult airway management and neostigmine which can cause myotonic response.

Česky

Kazuistika popisuje anesteziologický přístup k rodičce s myotonií congenita Becker. Poisuje výhodu monitorace hloubky nervosvalové blokády, použití rokuronia v bleskovém úvodu do celkové anestezie a jeho reverzi specifickým antagonistou sugammadexem.

Citovat

KOSINOVÁ, Martina; Petr ŠTOURAČ; Hana HARAZIM; Petr JANKŮ; Martin HUSER a Stanislav VOHÁŇKA. Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita. European Journal of Anaesthesiology. Philadelphia: Lippincott Williams & Wilkins, 2016, roč. 33, č. 7, s. 545-547. ISSN 0265-0215. Dostupné z: https://doi.org/10.1097/EJA.0000000000000442.

@article{1347027,
   author = {Kosinová, Martina and Štourač, Petr and Harazim, Hana and Janků, Petr and Huser, Martin and Voháňka, Stanislav},
   article_location = {Philadelphia},
   article_number = {7},
   doi = {https://doi.org/10.1097/EJA.0000000000000442},
   keywords = {cesarean delivery; Becker's myotonia congenita; general anaesthesia; sugammadex; rocuronium},
   language = {eng},
   issn = {0265-0215},
   journal = {European Journal of Anaesthesiology},
   title = {Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita},
   volume = {33},
   year = {2016}
}

TY  - JOUR
ID  - 1347027
AU  - Kosinová, Martina - Štourač, Petr - Harazim, Hana - Janků, Petr - Huser, Martin - Voháňka, Stanislav
PY  - 2016
TI  - Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita
JF  - European Journal of Anaesthesiology
VL  - 33
IS  - 7
SP  - 545-547
EP  - 545-547
PB  - Lippincott Williams & Wilkins
SN  - 02650215
KW  - cesarean delivery
KW  - Becker's myotonia congenita
KW  - general anaesthesia
KW  - sugammadex
KW  - rocuronium
N2  - Becker's Disease is an autosomal recessive type of myotonia congenita. Worldwide prevalence is about 1/100000. It is linked to mutations in CLCN1, the gene encoding skeletal muscle chloride channel. It reduces flow of chloride ions during repolarization and leads to sustained muscle contractions. Typical clinical symptoms are myotonic stiffness and “warm-up” phenomenon. 27 year old primipara with homozygote recessive mutation in CLCN1 (c.1437_1450del,p.480HfsX24) was indicated to elective caesarean section in 40 gestational week. In personal history she had thoracic stabilisation for scoliosis and hypothyreosis. We decided to provide the general anaesthesia with propofol in TCI mode (Schnider mode, C e =effective concentration 5 mcg/ml) and rocuronium 1 mg/kg IV for rapid sequence induction, monitoring the depth of neuromuscular blockade (NMB) on TOF WATCH SX device. The male newborn (APGAR score 9-10- 10) with no signs of pathology in acid-base balance in arterial umbilical blood was delivered. At the end of surgery (C e =1 mcg/ml, TOF=0, PTC=0) we administered sugammadex 4 mg/kg IV. It takes 2 min and 15 sec to reach TOF ratio 90% and subsequent extubation. After extubation she was breathing adequately, communicative, transferred to the recovery room and after two hours with no signs of residual NMB or respiratory problems back to the gynaecological ward to the monitored postoperative room. She was discharged home on 4 th day. This is the first report of anaesthetic management of a parturient with Becker's myotonia congenita who underwent CS under general anaesthesia. In this case we wanted to aware of using malignant hyperthermia (MH) triggering drugs, though the association with MH has been regarded as highly unlikely, suxamethonium which can cause total body rigidity and subsequent difficult airway management and neostigmine which can cause myotonic response.
ER  -

KOSINOVÁ, Martina; Petr ŠTOURAČ; Hana HARAZIM; Petr JANKŮ; Martin HUSER a Stanislav VOHÁŇKA. Anaesthesia and Orphan Disease: Rocuronium and Sugammadex in the Anaesthetic Management of a Parturient with Becker's Myotonia Congenita. \textit{European Journal of Anaesthesiology}. Philadelphia: Lippincott Williams \&{} Wilkins, 2016, roč.~33, č.~7, s.~545-547. ISSN~0265-0215. Dostupné z: https://doi.org/10.1097/EJA.0000000000000442.

Přehled o publikaci